ADNT
Adient PLC
Adient PLC historical holders
total: 4
Greenhaven Associates Adient PLC transactions over time
- Total transactions:
- 16
- New positions:
- 1
- Sold out:
- 1
- Added:
- 4
- Reduced:
- 10
- Held since:
- 2017 Q2
- Held for:
- 15 quarters
- Latest activity:
- 2021 Q1
Edgar Wachenheim III has been an institutional investor in Adient PLC (ADNT) since 2017 Q2. According to 2026 Q1 report, Edgar Wachenheim III doesn't hold any shares. The fund/company first acquired ADNT in 2017 Q2, initially purchasing about 1.61M shares. Since the initial investment, Greenhaven Associates has made 15 more transactions in this position.
When did Edgar Wachenheim III exit their ADNT position?
Edgar Wachenheim III no longer holds Adient PLC (ADNT). They sold off their entire position in 2021 Q1, closing out an investment that began in 2017 Q2.
When did Edgar Wachenheim III first invest in ADNT?
Edgar Wachenheim III first invested in Adient PLC (ADNT) in 2017 Q2 at the reported quarter-end price of $65.38 per share, acquiring 1,614,881 shares in their initial purchase.
What is Edgar Wachenheim III's average cost basis for ADNT?
Based on historical transaction data, Edgar Wachenheim III's estimated cost basis for Adient PLC (ADNT) is approximately $67.68 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $67.68
- Weighted AVG sell price:
- $32.23
ADNT transactions history by Greenhaven Associates
16 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q1
|
0.00%
|
0
|
$34.77
|
|
-100% (-1,460,196)
|
-0.96%
|
|
2020 Q4
|
0.96%
|
$34.77
|
-11.44% (-188,590)
|
|||
|
2020 Q3
|
0.63%
|
$17.33
|
-2.23% (-37,600)
|
|||
|
2020 Q2
|
0.61%
|
$16.42
|
-1.78% (-30,515)
|
|||
|
2020 Q1
|
0.58%
|
$9.07
|
-4.14% (-74,100)
|
|||
|
2019 Q4
|
0.85%
|
$21.25
|
+0.53% (+9,437)
|
|||
|
2019 Q3
|
0.83%
|
$22.96
|
-0.21% (-3,660)
|
|||
|
2019 Q2
|
0.76%
|
$24.27
|
-0.14% (-2,524)
|
|||
|
2019 Q1
|
0.41%
|
$12.96
|
-0.27% (-4,900)
|
|||
|
2018 Q4
|
0.52%
|
$15.06
|
-4.83% (-90,900)
|
|||
|
2018 Q3
|
1.15%
|
$39.31
|
-0.16% (-3,100)
|
|||
|
2018 Q2
|
1.39%
|
$49.19
|
-0.80% (-15,200)
|
|||
|
2018 Q1
|
1.79%
|
$59.76
|
+1.01% (+19,033)
|
|||
|
2017 Q4
|
2.24%
|
$78.70
|
+0.72% (+13,500)
|
|||
|
2017 Q3
|
2.36%
|
$83.99
|
+15.76% (+254,434)
|
|||
|
2017 Q2
|
1.60%
|
$65.38
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.